Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug

Published on 22 Nov 2024 on Zacks · via Yahoo Finance

REPL stock soars after submitting a BLA to the FDA seeking accelerated approval for its lead...

Read the rest of the article

Start tracking your investments with Statfolio

Tesla, Nvidia among Friday's market cap stock movers

Investing.com 22 Nov 2024

REPL stock soars after submitting a BLA to the FDA seeking accelerated approval for its lead...

Zacks · via Yahoo Finance 22 Nov 2024

Shares of Replimune Group Inc (NASDAQ:REPL) surged more than 19% in after-hours trading following...

Investing.com 22 Nov 2024

The shares were sold at a price of $10.78 each, amounting to a total transaction value of $78,111...

Investing.com 20 Nov 2024

According to a filing with the Securities and Exchange Commission, Sarchi sold 5,207 shares at a...

Investing.com 20 Nov 2024

Overview of the Recent Transaction On September 30, 2024, Morgan Stanley executed a significant t...

GuruFocus.com · via Yahoo Finance 8 Oct 2024

Shares of Replimune Group, Inc. (REPL) have gained 16.4% over the past four weeks to close the la...

Zacks via Yahoo Finance 11 Mar 2024

Replimune Group, Inc. (REPL) could be a solid choice for investors given its recent upgrade to a ...

Zacks via Yahoo Finance 8 Mar 2024

Shares of Replimune Group, Inc. (REPL) have gained 0.8% over the past four weeks to close the las...

Zacks via Yahoo Finance 23 Feb 2024

<img src=https://s.yimg.com/ny/api/res/1.2/GFFacjMQE5JFxUpwjOKI8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 8 Feb 2024